In this video, Dr. Tiziana Di Martino, chief medical officer at Q-linea, discusses the importance of rapid antimicrobial susceptibility testing (AST) and explains the growing need for accurate minimum inhibitory concentration (MIC) results. Di Martino also explores the key benefits of rapid AST technology and how an MIC is utilized within clinical practice to help guide vital antimicrobial treatments to patients.